日照工业吸尘器(达州工业吸尘器) (今日更新中)

JERUSALEM, March 31 (Xinhua) -- Two researchers at the Hebrew University (HU) of Jerusalem have been honored with a prestigious award for their study of the connection between several inflammatory diseases, cancer and bacteria.Medical faculty members, Dr. Eli Pilarsky and Prof. Sigal Ben- Yehuda, won this year's Sir Zelman Cowen Universities Fund prize that recognizes significant achievement in the field of medicine.The prize committee noted the impressive contributions of Pilarsky and Ben-Yehuda in understanding complex diseases like cancer and antibiotic-resistant infections, and, in a first, decided to award the two scientists this year.Pilarsky told Xinhua that his research deals with the connection between chronic inflammatory diseases like hepatitis, and the development of cancer cells."The relevance of this discovery is that we were able to establish the link between the molecules secreted with such inflammations and the proliferation of cancer cells," Pilarsky explained, noting that "we discovered that the inflammation favors the cancer cells' growth, and now we are trying to find a way to manipulate these molecules to stop the cancer cells from appearing. ""The importance of these findings lies in the fact that 20 percent of the world's cancer cases are attributed to inflammation processes," Pilarsky pointed out.

BEIJING, Feb. 15 (Xinhua) -- China's health authorities Tuesday vowed to improve their response to food safety incidents.The ministry would issue a protocol "as early as possible" on how to respond to and investigate food safety incidents, said Vice Health Minister Chen Xiaohong at a national meeting on food safety in Beijing.It would also provide better training for officials and professionals working in the field, Chen said.Last year, the ministry initiated investigations into several incidents such as milk powder that allegedly caused infant girls to grow breasts and illegal soup additives by restaurants.In the milk powder case, the investigation found no evidence that Synutra International's products had caused the problem. Media reports said the company was the victim of dirty tricks by a rival firm.In addition, the ministry blacklisted 48 substances illegally added to food and 22 misused food additives last year.The ministry would include projects related to food safety in state-sponsored health programs giving free medical services to the public in next five years, Health Minister Chen Zhu said at the same meeting.But Chen did not give details about what kind of projects they will be.Under the current six state health programs, the government provides free cataract surgery for the needy, free breast and cervical examinations for rural women, free hepatitis B vaccines, free folic acid pills for rural women, new cooking stoves in rural homes to prevent fluorine poisoning caused by coal stoves as well as modern toilets for rural residents.

BEIJING, May 21 (Xinhua) -- China's State Food and Drug Administration (SFDA) issued a circular on Friday banning the use of Nimesulide, an anti-inflammatory drug, for children under the age of 12, considering potential side-effects such as liver and kidney damage.Nimesulide is a non-steroidal anti-inflammatory drug that first became available in Italy in 1985. It is now used in more than 50 countries and regions.The drug entered Chinese markets in 1997.According to the SFDA, while common adverse reactions to the drug include vomiting and stomache, domestic and overseas statistics indicate that more severe issues are related to the drug, such as blood coagulation disorders, decreased white blood cells and damage to liver and kidney.Previously, the SFDA only prevented the use of the drug among children one year old or younger.Also on Friday, the SFDA ordered the suspension of the production, sales and use of Duxil (almitrine and raubasine compound) due to its "unobvious" efficacy.According to the SFDA, clinical research found "little" evidence proving the drug effectively improves the cognitive ability for patients suffering vascular cognitive impairment.The drug was supposed to treat symptoms related to cognition and sensory nerve damage.The moves came after a two-month nationwide campaign was launched earlier this month to probe the quality of essential drugs and ensure drug safety.Official figures show that China's National Center for Adverse Drug Reaction Monitoring received 692,904 reports of adverse reactions in 2010, up 8.4 percent compared with those in 2009.Among the total, 109,991 cases involved new or severe adverse reactions, a year-on-year increase of 16.2 percent.

NICOSIA, March 8 (Xinhua) -- Cypriot geneticists have reported a non-invasive Down's Syndrome test that could possibly replace the risky amniocentesis procedure now in use.A team of researchers at the Cyprus Institute of Neurology and Genetics reported in Nature Medicine journal that the new test involves only a small quantity of blood taken from the mother's arm, which is analyzed to detect DNA differences between the mother and the fetus.Philippos Patsalis, medical director of the institute, said Tuesday the new method eliminates dangers involved with amniocentesis testing, which involves sampling amniotic fluid by inserting a hollow needle into the mother's uterus.At present, only women belonging to high risk groups, including older women, are tested for Down's Syndrome, which is the most common genetic cause of mental retardation.Patsalis, who led the study, said the new method would be made available to the medical community after clinical tests are concluded world-wide on 1,000 women within two years.

WASHINGTON, May 3 (Xinhua) -- People diagnosed with asthma in the United States grew by 4.3 million between 2001 and 2009, according to a new report released Tuesday by the Centers for Disease Control and Prevention (CDC).In 2009, nearly one in 12 Americans were diagnosed with asthma. In addition to increased diagnoses, asthma costs grew from about 53 billion U.S. dollars in 2002 to about 56 billion dollars in 2007, about a six percent increase. The explanation for the growth in asthma rates is unknown, according to the CDC.Asthma is a lifelong disease that causes wheezing, breathlessness, chest tightness, and coughing, though people with asthma can control symptoms and prevent asthma attacks by avoiding things that can set off an asthma attacks, and correctly using prescribed medicine, like inhaled corticosteroids. The report highlights the benefits of essential asthma education and services that reduce the impact of these triggers, but most often these benefits are not covered by health insurers."Despite the fact that outdoor air quality has improved, we've reduced two common asthma triggers -- secondhand smoke and smoking in general -- asthma is increasing," said Paul Garbe, chief of CDC 's Air Pollution and Respiratory Health Branch. "While we don't know the cause of the increase, our top priority is getting people to manage their symptoms better."Asthma triggers are usually environmental and can be found at school, work, home, outdoors, and elsewhere and can include tobacco smoke, mold, outdoor air pollution, and infections linked to influenza, cold-like symptoms, and other viruses.According to the report, asthma diagnoses increased among all demographic groups between 2001 and 2009, though a higher percentage of children reported having asthma than adults (9.6 percent compared to 7.7 percent in 2009). Annual asthma costs in the United States were 3,300 dollars per person with asthma from 2002 to 2007 in medical expenses. About two in five uninsured and one in nine insured people with asthma could not afford their prescription medication."Asthma is a serious, lifelong disease that unfortunately kills thousands of people each year and adds billions to our nation's health care costs," said CDC Director Thomas Frieden. "We have to do a better job educating people about managing their symptoms and how to correctly use medicines to control asthma so they can live longer more productive lives while saving health care costs."

来源：资阳报